Control of antibiotic-resistant bacteria in the office and clinic

Matlow, Anne G.; Morris, Shaun K.
May 2009
CMAJ: Canadian Medical Association Journal;5/12/2009, Vol. 180 Issue 10, p1021
Academic Journal
The article discusses how to control the prevalence of the antibiotic-resistant bacteria in the ambulatory care settings in the U.S. The emergence of the vancomycin-resistant Enterococcus and Clostridium difficile and the transmission of the methicillin resistant staphylococcus aureus (MRSA) in the office and clinic is very rare. However, a routine infection-control measures are still needed, as well as an ongoing surveillance which will identify the epidemiology of the colonization and infection. The use of antimicrobials and hand hygiene are best ways to prevent and control the bacteria.


Related Articles

  • Progress made against MRSA but more measures needed. Kohlway, Elizabeth // Nation's Health;Aug2008, Vol. 38 Issue 6, p8 

    The article focuses on a survey released in June 2008 by the Association for Professionals in Infection Control and Epidemiology which found that health professionals in the U.S. are making progress in preventing methicillin-resistant Staphylococcus aureus in health care settings. According to...

  • Activity of Fusidic Acid Against Extracellular and Intracellular Staphylococcus aureus: Influence of pH and Comparison With Linezolid and Clindamycin. Lemaire, Sandrine; Van Bambeke, Francoise; Pierard, Denis; Appelbaum, Peter C.; Tulkens, Paul M. // Clinical Infectious Diseases;2011, Vol. 52 Issue Suppl 7, pS493 

    Background. Emergence of multidrug-resistant Staphylococcus aureus has triggered a reassessment of fusidic acid (CEM-102, sodium fusidate).Methods. Fusidic acid was examined for (1) activity against recent methicillin-resistant S. aureus (MRSA) isolates; (2) modulation of activity by acidic pH;...

  • Golden Staph Escapes Hospitals.  // Australasian Science;Jun2006, Vol. 27 Issue 5, p8 

    Presents information on the cases of hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) in Australia. Reason behind the drop in HA-MRSA from 2002 to 2004; Resistance of bacteria that are already resistant to methicillin to other antibiotics; Importance of studies of new...

  • Daptomycin Resistance in Vancomycin-Intermediate Staphylococcus Aureus Isolate. Amchentsev, Alexey; Devakonda, Arun; Abraham, Teena; Saad, Nasser; Vastey, Fabienne; Colby, Steven; George, Liziamma // Internet Journal of Infectious Diseases;2009, Vol. 7 Issue 2, p6 

    We describe a patient with methicillin-resistant Staphylococcus aureus (MRSA) who developed resistance to daptomycin, a new cyclic lipopeptide recently approved for the treatment of infections by gram-positive organisms. Development of resistance to daptomycin during prolonged use may occur with...

  • A Population-Based Study of the Incidence and Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Disease in San Francisco, 2004-2005. Liu, Catherine; Graber, Christopher J.; Karr, Michael; Diep, Binh An; Basuino, Li; Schwartz, Brian S.; Enright, Mark C.; O'Hanlon, Simon J.; Thomas, Jonathon C.; Perdreau-Remington, Francoise; Gordon, Shelley; Gunthorpe, Helen; Jacobs, Richard; Jensen, Peter; Leoung, Gifford; Rumack, James S.; Chambers1,2, Henry F. // Clinical Infectious Diseases;6/1/2008, Vol. 46 Issue 11, p1637 

    Background. Methicillin-resistant Staphylococcus aureus (MRSA) infections have become a major public health problem in both the community and hospitals. Few studies have characterized the incidence and clonal composition of disease-causing strains in an entire population. Our objective was to...

  • Recommendations for surveillance priorities for healthcare-associated infections and criteria for their conduct. Wilson, A. P. R.; Kiernan, M. // Journal of Antimicrobial Chemotherapy (JAC);Jul2012 Supplement 1, Vol. 67 Issue suppl_1, pi23 

    Surveillance and feedback of results to clinical teams is central to performance improvement in managing healthcare-acquired infections. A major role of the Advisory Committee on Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) is to advise on surveillance priorities. A...

  • Current challenges in antimicrobial resistance and healthcare-associated infections: role and organization of ARHAI. Finch, Roger // Journal of Antimicrobial Chemotherapy (JAC);Jul2012 Supplement 1, Vol. 67 Issue suppl_1, pi3 

    The UK Government Specialist Advisory Committee on Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) was established in 2007. It has responsibility for providing practical and scientific advice to government on healthcare-associated infections (HCAIs) and to maintain the...

  • INFECTION CONTROL NURSES DEMAND DATA ON BACTERIUM. houdhari, Huria // Nursing Standard;6/15/2005, Vol. 19 Issue 40, p10 

    This article reports that nurses have called for more comprehensive collection of data on the bacterium Clostridium difficile amid concerns that it is endemic in some hospitals. The bacterium, which accounted for almost 44,000 hospital-acquired infections in Great Britain last year, is as...

  • A prospective study to examine the epidemiology of methicillin-resistant Staphylococcus aureus and Clostridium difficile contamination in the general environment of three community hospitals in southern Ontario, Canada. Faires, Meredith C.; Pearl, David L.; Ciccotelli, William A.; Straus, Karen; Zinken, Giovanna; Berke, Olaf; Reid-Smith, Richard J.; Weese, J. Scott // BMC Infectious Diseases;2012, Vol. 12 Issue 1, p290 

    Background: The hospital environment has been suggested as playing an important role in the transmission of hospital-associated (HA) pathogens. However, studies investigating the contamination of the hospital environment with methicillin-resistant Staphylococcus aureus (MRSA) or Clostridium...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics